[HTML][HTML] Combination of serum and peritoneal 1.3-beta-d-glucan can rule out intra-abdominal candidiasis in surgical critically ill patients: a multicenter prospective …
Background Intra-abdominal candidiasis (IAC) is difficult to predict in critically ill patients with
intra-abdominal infection, leading to the overuse of antifungal treatments. Serum and …
intra-abdominal infection, leading to the overuse of antifungal treatments. Serum and …
Combination of serum and peritoneal 1.3-beta-D-glucan can rule out intra-abdominal candidiasis in surgical critically ill patients: a multicenter prospective study
E Novy, J Rivière, M Nguyen… - Critical care …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Intra-abdominal candidiasis (IAC) is difficult to predict in critically ill patients with
intra-abdominal infection, leading to the overuse of antifungal treatments. Serum and …
intra-abdominal infection, leading to the overuse of antifungal treatments. Serum and …
[HTML][HTML] Combination of serum and peritoneal 1.3-beta-d-glucan can rule out intra-abdominal candidiasis in surgical critically ill patients: a multicenter prospective …
E Novy, J Rivière, M Nguyen, G Arfeuille, G Louis… - Critical Care, 2023 - ncbi.nlm.nih.gov
Background Intra-abdominal candidiasis (IAC) is difficult to predict in critically ill patients with
intra-abdominal infection, leading to the overuse of antifungal treatments. Serum and …
intra-abdominal infection, leading to the overuse of antifungal treatments. Serum and …
Combination of serum and peritoneal 1.3-beta-d-glucan can rule out intra-abdominal candidiasis in surgical critically ill patients: a multicenter prospective study
E Novy, J Rivière, M Nguyen, G Arfeuille, G Louis… - Critical Care, 2023 - hal.science
Background Intra-abdominal candidiasis (IAC) is difficult to predict in critically ill patients with
intra-abdominal infection, leading to the overuse of antifungal treatments. Serum and …
intra-abdominal infection, leading to the overuse of antifungal treatments. Serum and …
Combination of serum and peritoneal 1.3-beta-d-glucan can rule out intra-abdominal candidiasis in surgical critically ill patients: a multicenter prospective study
E Novy, J Rivière, M Nguyen, G Arfeuille, G Louis… - Critical …, 2023 - hal.univ-lorraine.fr
Background Intra-abdominal candidiasis (IAC) is difficult to predict in critically ill patients with
intra-abdominal infection, leading to the overuse of antifungal treatments. Serum and …
intra-abdominal infection, leading to the overuse of antifungal treatments. Serum and …
Combination of serum and peritoneal 1.3-beta-D-glucan can rule out intra-abdominal candidiasis in surgical critically ill patients: a multicenter prospective study.
E Novy, J Rivière, M Nguyen, G Arfeuille… - Critical Care (London …, 2023 - europepmc.org
Background Intra-abdominal candidiasis (IAC) is difficult to predict in critically ill patients with
intra-abdominal infection, leading to the overuse of antifungal treatments. Serum and …
intra-abdominal infection, leading to the overuse of antifungal treatments. Serum and …
[HTML][HTML] Combination of serum and peritoneal 1.3-beta-d-glucan can rule out intra-abdominal candidiasis in surgical critically ill patients: a multicenter prospective …
E Novy, J Rivière, M Nguyen, G Arfeuille… - Critical …, 2023 - ccforum.biomedcentral.com
Intra-abdominal candidiasis (IAC) is difficult to predict in critically ill patients with intra-
abdominal infection, leading to the overuse of antifungal treatments. Serum and peritoneal …
abdominal infection, leading to the overuse of antifungal treatments. Serum and peritoneal …
Combination of serum and peritoneal 1.3-beta-d-glucan can rule out intra-abdominal candidiasis in surgical critically ill patients: a multicenter prospective study
E Novy, J Rivière, M Nguyen, G Arfeuille… - Critical …, 2023 - search.proquest.com
Background Intra-abdominal candidiasis (IAC) is difficult to predict in critically ill patients with
intra-abdominal infection, leading to the overuse of antifungal treatments. Serum and …
intra-abdominal infection, leading to the overuse of antifungal treatments. Serum and …
Combination of serum and peritoneal 1.3-beta-d-glucan can rule out intra-abdominal candidiasis in surgical critically ill patients: a multicenter prospective study.
E Novy, J Rivière, M Nguyen, G Arfeuille… - Critical …, 2023 - search.ebscohost.com
Background: Intra-abdominal candidiasis (IAC) is difficult to predict in critically ill patients
with intra-abdominal infection, leading to the overuse of antifungal treatments. Serum and …
with intra-abdominal infection, leading to the overuse of antifungal treatments. Serum and …
Combination of serum and peritoneal 1.3-beta-D-glucan can rule out intra-abdominal candidiasis in surgical critically ill patients: a multicenter prospective study.
E Novy, J Rivière, M Nguyen, G Arfeuille… - Critical Care (London …, 2023 - europepmc.org
Background Intra-abdominal candidiasis (IAC) is difficult to predict in critically ill patients with
intra-abdominal infection, leading to the overuse of antifungal treatments. Serum and …
intra-abdominal infection, leading to the overuse of antifungal treatments. Serum and …